Try our Advanced Search for more refined results

In Win For Barr, Court Denies Tamoxifen Rehearing

By Erin Marie Daly ( September 18, 2006, 12:00 AM EDT) -- Marking a victory for Barr Pharmaceuticals Inc. in a long-running case over authorized generics, the U.S. Court of Appeals for the Second Circuit has denied a bid for rehearing by a group of consumers in the Tamoxifen Citrate antitrust lawsuits....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies